INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

본 발명은, 바리셀라 조스터 바이러스 (VZV)의 감염성이 검출불가능하며 환자에게 투여되는 경우 VZV에 대한 면역 반응을 유도하는 것인 불활성화된 VZV, 및 상기 불활성화된 VZV를 포함하는 조성물 및 백신을 제공한다. 본원에 기재된 조성물의 실시양태에서, VZV는 감마선에 의해 불활성화된다. 본 발명은 또한 약 5 kGy 내지 약 50 kGy의 감마선을 사용하여 VZV를 포함하는 샘플을 감마 조사하는 단계를 포함하는, 불활성화된 VZV 백신의 제조 방법을 제공한다. 본 발명은 또한 본원에서 치료 유효량의 불활성화된 VZV 및...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAGODICH MARY, BARR COLLEEN M, DEHAVEN JILL, KRISS JENNIFER A, KRAH DAVID L
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAGODICH MARY
BARR COLLEEN M
DEHAVEN JILL
KRISS JENNIFER A
KRAH DAVID L
description 본 발명은, 바리셀라 조스터 바이러스 (VZV)의 감염성이 검출불가능하며 환자에게 투여되는 경우 VZV에 대한 면역 반응을 유도하는 것인 불활성화된 VZV, 및 상기 불활성화된 VZV를 포함하는 조성물 및 백신을 제공한다. 본원에 기재된 조성물의 실시양태에서, VZV는 감마선에 의해 불활성화된다. 본 발명은 또한 약 5 kGy 내지 약 50 kGy의 감마선을 사용하여 VZV를 포함하는 샘플을 감마 조사하는 단계를 포함하는, 불활성화된 VZV 백신의 제조 방법을 제공한다. 본 발명은 또한 본원에서 치료 유효량의 불활성화된 VZV 및 제약상 허용되는 담체를 포함하며 상기 VZV가 감마 조사에 의해 불활성화된 것인 백신 또는 제약 조성물을 대상체에게 투여하는 단계를 포함하는, HZ 또는 VZV의 재활성화와 관련된 다른 질환의 치료 방법 또는 이들에 대한 면역화 방법을 제공한다. The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20160018828A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20160018828A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20160018828A3</originalsourceid><addsrcrecordid>eNqNi7EKwjAUALM4iPoPD1wrpBUka0heSLAmkrxkcClF4iRaqP-PHfwAp4Pjbs3IeanIFUmoocjoFPa9hFtIhBGKizktWinnMTVwQbJBJwgGrjHovJzBNyC9hpwwAVmMGMyWrR7jc667Hzdsb5CUPdTpPdR5Gu_1VT_DOXa8PXHeCtEJefyv-gL99DES</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF</title><source>esp@cenet</source><creator>YAGODICH MARY ; BARR COLLEEN M ; DEHAVEN JILL ; KRISS JENNIFER A ; KRAH DAVID L</creator><creatorcontrib>YAGODICH MARY ; BARR COLLEEN M ; DEHAVEN JILL ; KRISS JENNIFER A ; KRAH DAVID L</creatorcontrib><description>본 발명은, 바리셀라 조스터 바이러스 (VZV)의 감염성이 검출불가능하며 환자에게 투여되는 경우 VZV에 대한 면역 반응을 유도하는 것인 불활성화된 VZV, 및 상기 불활성화된 VZV를 포함하는 조성물 및 백신을 제공한다. 본원에 기재된 조성물의 실시양태에서, VZV는 감마선에 의해 불활성화된다. 본 발명은 또한 약 5 kGy 내지 약 50 kGy의 감마선을 사용하여 VZV를 포함하는 샘플을 감마 조사하는 단계를 포함하는, 불활성화된 VZV 백신의 제조 방법을 제공한다. 본 발명은 또한 본원에서 치료 유효량의 불활성화된 VZV 및 제약상 허용되는 담체를 포함하며 상기 VZV가 감마 조사에 의해 불활성화된 것인 백신 또는 제약 조성물을 대상체에게 투여하는 단계를 포함하는, HZ 또는 VZV의 재활성화와 관련된 다른 질환의 치료 방법 또는 이들에 대한 면역화 방법을 제공한다. The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.</description><language>eng ; kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160217&amp;DB=EPODOC&amp;CC=KR&amp;NR=20160018828A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160217&amp;DB=EPODOC&amp;CC=KR&amp;NR=20160018828A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAGODICH MARY</creatorcontrib><creatorcontrib>BARR COLLEEN M</creatorcontrib><creatorcontrib>DEHAVEN JILL</creatorcontrib><creatorcontrib>KRISS JENNIFER A</creatorcontrib><creatorcontrib>KRAH DAVID L</creatorcontrib><title>INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF</title><description>본 발명은, 바리셀라 조스터 바이러스 (VZV)의 감염성이 검출불가능하며 환자에게 투여되는 경우 VZV에 대한 면역 반응을 유도하는 것인 불활성화된 VZV, 및 상기 불활성화된 VZV를 포함하는 조성물 및 백신을 제공한다. 본원에 기재된 조성물의 실시양태에서, VZV는 감마선에 의해 불활성화된다. 본 발명은 또한 약 5 kGy 내지 약 50 kGy의 감마선을 사용하여 VZV를 포함하는 샘플을 감마 조사하는 단계를 포함하는, 불활성화된 VZV 백신의 제조 방법을 제공한다. 본 발명은 또한 본원에서 치료 유효량의 불활성화된 VZV 및 제약상 허용되는 담체를 포함하며 상기 VZV가 감마 조사에 의해 불활성화된 것인 백신 또는 제약 조성물을 대상체에게 투여하는 단계를 포함하는, HZ 또는 VZV의 재활성화와 관련된 다른 질환의 치료 방법 또는 이들에 대한 면역화 방법을 제공한다. The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EKwjAUALM4iPoPD1wrpBUka0heSLAmkrxkcClF4iRaqP-PHfwAp4Pjbs3IeanIFUmoocjoFPa9hFtIhBGKizktWinnMTVwQbJBJwgGrjHovJzBNyC9hpwwAVmMGMyWrR7jc667Hzdsb5CUPdTpPdR5Gu_1VT_DOXa8PXHeCtEJefyv-gL99DES</recordid><startdate>20160217</startdate><enddate>20160217</enddate><creator>YAGODICH MARY</creator><creator>BARR COLLEEN M</creator><creator>DEHAVEN JILL</creator><creator>KRISS JENNIFER A</creator><creator>KRAH DAVID L</creator><scope>EVB</scope></search><sort><creationdate>20160217</creationdate><title>INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF</title><author>YAGODICH MARY ; BARR COLLEEN M ; DEHAVEN JILL ; KRISS JENNIFER A ; KRAH DAVID L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20160018828A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YAGODICH MARY</creatorcontrib><creatorcontrib>BARR COLLEEN M</creatorcontrib><creatorcontrib>DEHAVEN JILL</creatorcontrib><creatorcontrib>KRISS JENNIFER A</creatorcontrib><creatorcontrib>KRAH DAVID L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAGODICH MARY</au><au>BARR COLLEEN M</au><au>DEHAVEN JILL</au><au>KRISS JENNIFER A</au><au>KRAH DAVID L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF</title><date>2016-02-17</date><risdate>2016</risdate><abstract>본 발명은, 바리셀라 조스터 바이러스 (VZV)의 감염성이 검출불가능하며 환자에게 투여되는 경우 VZV에 대한 면역 반응을 유도하는 것인 불활성화된 VZV, 및 상기 불활성화된 VZV를 포함하는 조성물 및 백신을 제공한다. 본원에 기재된 조성물의 실시양태에서, VZV는 감마선에 의해 불활성화된다. 본 발명은 또한 약 5 kGy 내지 약 50 kGy의 감마선을 사용하여 VZV를 포함하는 샘플을 감마 조사하는 단계를 포함하는, 불활성화된 VZV 백신의 제조 방법을 제공한다. 본 발명은 또한 본원에서 치료 유효량의 불활성화된 VZV 및 제약상 허용되는 담체를 포함하며 상기 VZV가 감마 조사에 의해 불활성화된 것인 백신 또는 제약 조성물을 대상체에게 투여하는 단계를 포함하는, HZ 또는 VZV의 재활성화와 관련된 다른 질환의 치료 방법 또는 이들에 대한 면역화 방법을 제공한다. The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; kor
recordid cdi_epo_espacenet_KR20160018828A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T08%3A20%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAGODICH%20MARY&rft.date=2016-02-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20160018828A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true